In the demanding arena of clinical wound management, the transition from being a consumer of research to a contributor of evidence is a hallmark of the responsible clinical professional. While Randomized Controlled Trials (RCTs) dominate the peak of the evidence hierarchy, they often fail to capture the nuances of the individual “non-average” patient. Your clinical observations are the frontline of discovery. This guide is designed to help you elevate those observations into a structured, scholarly manuscript that can withstand the scrutiny of peer review and contribute to the global body of clinical knowledge.
1. Introduction: The Strategic Value of the Clinical Story
In the landscape of evidence-based practice, we must distinguish between different study designs to understand their utility. According to Bolton (2007), the Prospective Randomized Controlled Trial (RCT) is the “strongest evidence” for determining comparative safety and efficacy because it utilizes blinded, randomized groups to minimize bias.
In contrast, the case study is often classified as the “weakest evidence.” It is essential to understand why this skepticism exists: case studies are anecdotal descriptions of how a condition was managed, frequently suffering from “biased patient selection” and a lack of data regarding “exposure to causative factors” (Bolton, Table 1).
However, as an editor, I view the case study as a vital “anecdotal description” that serves as the engine for new research. They are indispensable for:
- Identifying unusual clinical responses or adverse reactions to treatment.
- Introducing the interprofessional team to the performance of a new product.
- Describing the application of an existing product for a new indication.
2. Determining Clinical Significance: Is Your Case Ready for the Byline?
Not every successful healing outcome warrants publication. A case study achieves “clinical significance” when it addresses a gap in the collective knowledge of the profession. Focus your manuscript on cases that meet the following criteria:
- Unusual Clinical Responses: Unexpected outcomes or adverse reactions that deviate from standard expectations (Bolton 2007).
- Novel Product Application: Performance data on new technologies or existing tools used in unproven ways (Bolton 2007).
- Addressing Evidence Gaps: Clinical scenarios where current Clinical Practice Guidelines (CPGs) lack sufficient evidence to make a recommendation (SELECT 2010).
- Expert Knowing: Cases where “clinical knowledge” and expert opinion are required to guide care because higher-level evidence is non-existent (SELECT 2010).
3. The Blueprint: A Rigorous Workflow
Writing a case study is akin to building a house; without a blueprint, the structure will collapse under the weight of academic review. Follow this 8-step research format adapted from Bolton (2007) to ensure methodological integrity:
- Formulate the Question: Identify the specific clinical gap you are addressing.
- Search Prior Literature: Use a systematic approach to determine what is already known.
- Develop a Specific Objective: Define exactly what you intend to describe (e.g., safety, performance, or ease of use).
- Write the Protocol: This is your “blueprint.” It defines inclusion criteria and treatment duration before the study begins.
- Obtain Resources and Permissions: Secure institutional support (IRB, administration) and patient consent.
- Conduct the Study: Apply treatments and observe effects with meticulous diligence.
- Analyze the Results: Review your data against your original objective.
- Write the Conclusions: Summarize findings without making assumptions beyond the population studied.
4. Drafting the Content: The Clinical Data Checklist
To produce a publishable manuscript, your documentation must be objective, reliable, and repeatable. Avoid vague, subjective descriptions. Use the following checklist to ensure your “Data Collection Form” is comprehensive:
Patient History and Baseline Variables
- Demographics: Age, sex, and mobility level (Bolton 2007).
- Nutritional Sufficiency: You must report specific markers beyond simple “diet.” Include Albumin or Prealbumin (for protein sufficiency), Transferritin (to assess iron transport), and Lymphocyte Count (to identify immunosuppression) (Bolton, p. 59).
- Comorbidities: Document blood glucose control (Hemoglobin A1c for diabetic patients) and renal function.
Wound Assessment
Documentation must include:
- Wound area and depth.
- Presence of necrosis and exudate type/amount.
- Condition of surrounding skin.
- Patient-reported pain levels.
Intervention and Environmental Constraints
Include “environmental elements” that impact outcomes, such as caregiver status, financial constraints, or footwear issues (Bolton 2007).
Measured Outcomes
Healing must be measured using objective tools. Length x Width measurements must be recorded consistently at regular timeframes (Bolton, p. 64). Consistency in timing is as important as the tool itself for maintaining the validity of the results.
5. Anchoring Your Case: Literature and Guidelines
A case study does not exist in a vacuum; it must be anchored in the broader scientific landscape.
The Search Framework
Use the PICU/PICO framework to focus your literature search: Patient, problem, or population; Intervention; Comparison; and Outcome (Smith 2015, p. 2). This ensures you are searching for a specific population type or problem, not just an individual.
Evidence-Informed Practice (The SELECT Model)
Your case study should reflect the SELECT (2010) model of “Evidence-Informed Practice.” As seen in Figure 2 (p. 163), clinical decisions should occur at the overlap of four interlocking rings:
- Research Evidence
- Clinical Knowledge (Expert opinion)
- Clinical Circumstance/Healthcare Resources
- Patient Values (Which must sit at the center of the model).
6. Ethical Mandates and Legal Protections
The legal and ethical requirements of clinical research are non-negotiable. Failure to adhere to these standards can result in legal liability for both the nurse and the institution.
- Informed Consent: This is the patient’s right, guaranteed by the Helsinki Accord. The patient must understand the purpose of the study and their participation must be compliant and voluntary (Bolton 2007).
- Institutional Review Board (IRB): Check IRB requirements before initiating any investigation.
- OFF-LABEL WARNING: If you are asked to investigate a marketed product for an unapproved indication, you and your institution bear full legal responsibility for any adverse events (Bolton, p. 62).
- Facility Permission: Secure administrative support to ensure your study conforms to “Good Clinical Practice.”
7. Submission and the Concept of Research Impact
The goal of your work is “Research Impact.” As defined by Greenhalgh (2016), impact occurs when research generates benefits to health, society, or quality of life that extend beyond the academic knowledge base.
- Internal Impact: Using your case study to update local facility directives or policies is a form of “societal benefit” because it improves care for your specific patient population (Greenhalgh 2016, Box 1; SELECT 2010).
- External Dissemination: Submit to journals with dedicated case study sections or present your findings at professional conferences to alert the interprofessional community to new findings.
8. Conclusion: The “Take-Home Message” for Practice
Transitioning from a clinician to an author requires you to become a “responsible clinical professional” who no longer accepts product claims at face value (Bolton 2007, p. 57). You must scrutinize the quality of information you receive and rely on the strongest, most clinically relevant evidence available. By documenting and sharing significant clinical cases, you contribute to a culture of evidence-informed decisions that move beyond “it worked before” and elevate the standard of care for every patient you serve.